Vanguard Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.74M Sell
96,394
-7,264
-7% -$130K ﹤0.01% 3605
2025
Q3
$1.92M Buy
103,658
+11,739
+13% +$184K ﹤0.01% 3591
2025
Q2
$1.47M Buy
91,919
+8,712
+10% +$155K ﹤0.01% 3638
2025
Q1
$1.62M Buy
83,207
+20,259
+32% +$426K ﹤0.01% 3559
2024
Q4
$1.39M Buy
62,948
+8,976
+17% +$173K ﹤0.01% 3666
2024
Q3
$909K Buy
53,972
+6,342
+13% +$94.1K ﹤0.01% 3807
2024
Q2
$569K Buy
47,630
+17,534
+58% +$196K ﹤0.01% 3958
2024
Q1
$333K Hold
30,096
﹤0.01% 4095
2023
Q4
$261K Hold
30,096
﹤0.01% 4181
2023
Q3
$230K Buy
30,096
+9,934
+49% +$74.6K ﹤0.01% 4229
2023
Q2
$145K Hold
20,162
﹤0.01% 4357
2023
Q1
$123K Hold
20,162
﹤0.01% 4381
2022
Q4
$87.9K Hold
20,162
﹤0.01% 4405
2022
Q3
$79K Hold
20,162
﹤0.01% 4512
2022
Q2
$103K Hold
20,162
﹤0.01% 4545
2022
Q1
$129K Hold
20,162
﹤0.01% 4579
2021
Q4
$162K Buy
+20,162
New +$190K ﹤0.01% 4579

Other funds holding CLBT